← back to search

Andrea Kay

Basildon Hospital ·

Area of research

Pulmonary and Respiratory Medicine · Infectious Diseases

Research interest

Research interests include Renal cell carcinoma treatment, COVID-19 Clinical Research Studies, Fibroblast Growth Factor Research, and SARS-CoV-2 and COVID-19 Research.

h-index

35

citations

13,896

works

88

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma

Clinical Cancer Research 2013cited by 130position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Shi · Hua Medicine (China)1 papers (2013–2013)Paramita Sen · Eli Lilly (United States)1 papers (2013–2013)Jean‐Charles Soria · Institut Gustave Roussy1 papers (2013–2013)Daniel Castellano · Universidad Complutense de Madrid1 papers (2013–2013)Eric Angevin · Inserm1 papers (2013–2013)Julie Chang · Hawaiian Volcano Observatory1 papers (2013–2013)Chia‐Chi Lin · National Taiwan University Hospital1 papers (2013–2013)Bernard Escudier · Institut Gustave Roussy1 papers (2013–2013)Andrea Harzstark · Kaiser Permanente1 papers (2013–2013)Jürgen E. Gschwend · Institut für Arbeitsmarkt und Berufsforschung1 papers (2013–2013)José A. López-Martín · PharmaMar (Spain)1 papers (2013–2013)